Showing results (761-770 of 783) with videos related to
Sort By:
Pageof 79
Pediatric Nephrology (Berlin, Germany)|June 10, 2025
Growth dynamics of transversal body dimensions and proportions, with related clinical determinants in children with X-linked hypophosphatemia treated with phosphate supplements and active vitamin DLaura Celine Brieger, Stephan Przygodda, Alina Verena Bohlen, et al.The Journal of Clinical Investigation|March 12, 2024
Neutralizing IFN-γ autoantibodies are rare and pathogenic in HLA-DRB1*15:02 or 16:02 individualsJessica N Peel, Rui Yang, Tom Le Voyer, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 3, 2024
Neutral or Detrimental Effects of TREM2 Agonist Antibodies in Preclinical Models of Alzheimer's Disease and Multiple SclerosisAinhoa Etxeberria, Yun-An A Shen, Stephen Vito, et al.Pediatric Nephrology (Berlin, Germany)|April 10, 2026
Anthropometric characteristics at birth and growth outcome in patients with X-linked hypophosphatemia treated with oral phosphate and active vitamin DStephan Przygodda, Laura Celine Brieger, Alina Verena Bohlen, et al.The Journal of Experimental Medicine|November 3, 2022
Inherited human ITK deficiency impairs IFN-γ immunity and underlies tuberculosisMasato Ogishi, Rui Yang, Rémy Rodriguez, et al.The Journal of Experimental Medicine|June 16, 2022
Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumoniaQian Zhang, Daniela Matuozzo, Jérémie Le Pen, et al.Science Immunology|May 30, 2025
Human LY9 governs CD4+ T cell IFN-γ immunity to Mycobacterium tuberculosisMasato Ogishi, Julia Puchan, Rui Yang, et al.Science Immunology|February 10, 2023
Human IL-23 is essential for IFN-γ-dependent immunity to mycobacteriaQuentin Philippot, Masato Ogishi, Jonathan Bohlen, et al.Cell|October 24, 2023
Human MCTS1-dependent translation of JAK2 is essential for IFN-γ immunity to mycobacteriaJonathan Bohlen, Qinhua Zhou, Quentin Philippot, et al.Immunity|November 27, 2024
Impaired development of memory B cells and antibody responses in humans and mice deficient in PD-1 signalingMasato Ogishi, Koji Kitaoka, Kim L Good-Jacobson, et al.Pageof 79